Skip to content
★ Sign in to follow
IP

Infinium Pharmachem Limited Stock: price and insider trades · India

IN·Mcap ₹3BHealth Care

Infinium Pharmachem Limited: what insiders have been doing

We have very little insider data for Infinium Pharmachem Limited so far: the most recent filing dates from 21 July 2025. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.

Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 13,699 of 26,911 companies
50.9
score / 100
Value
56
Quality
46
FCF yld8.0%
Earn yld4.0%
EV/EBITDA14.7x
ROE·
Gross mgn22%
Net mgn6.4%
Debt/EBITDA2.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹222.95
Income statement
Revenue₹1.9B
Gross profit₹410.9M22% margin
EBITDA₹237M12% margin
Net income₹121.5M6.4% margin
Balance sheet & cash
Market cap₹3B
Total debt₹473.2M
Free Cash Flow₹240.5M
Last declaration on 21 July 2025
Declarations4 total

4 of 4 declarations

About Infinium Pharmachem Limited

Infinium Pharmachem Limited is a company specializing in the health and pharmaceutical sector. It is listed on the XBOM.